Tumor-associated immune cells hinder frontline chemotherapy drug in pancreatic cancer

A frontline chemotherapy drug given to patients with pancreatic cancer is made less effective because similar compounds released by tumor-associated immune cells block the drug’s action.

Leave a Reply

Your email address will not be published. Required fields are marked *